REQUEST A DEMO
Total
USD $0.00
Search more companies

Medirol S.R.O. (Czech Republic)

Main Activities: Medical Equipment and Supplies Manufacturing
Full name: Medirol S.R.O. Profile Updated: September 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Medirol S.R.O. is a company based in Czech Republic, with its head office in Prague. The enterprise operates in the Medical Equipment and Supplies Manufacturing industry. It was first established on March 11, 1996. The total number of employees is currently 25 - 49 (2024). In its most recent financial highlights, the company reported a net sales revenue increase of 58.86% in 2022. A growth of 43.36% was recorded in its total assets. The net profit margin of Medirol S.R.O. increased by 4.54% in 2022.

Headquarters
Na strzi 126/4
Prague; The City of Prague; Postal Code: 14000

Contact Details: Purchase the Medirol S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Medirol S.R.O. report to view the information.
Outstanding Shares:
Purchase the Medirol S.R.O. report to view the information.
Registered Capital:
Purchase the Medirol S.R.O. report to view the information.
Incorporation Date:
March 11, 1996
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Medirol S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
58.86%
Total operating revenue
58.68%
Operating profit (EBIT)
119.77%
EBITDA
82.06%
Net Profit (Loss) for the Period
143.35%
Total assets
43.36%
Total equity
30.16%
Operating Profit Margin (ROS)
4.2%
Net Profit Margin
4.54%
Return on Equity (ROE)
10.77%
Debt to Equity Ratio
-0.3%
Quick Ratio
-0.98%
Cash Ratio
-0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?